Varaico: Literature-Extracted Genetic Variants

Gene:CHIT1
Variant:p.E409G
Back to variants list

CHIT1

NM_003465.3:p.E409G

Associated Papers

Early diagnosis and management in Gaucher disease: A case series emphasizing the critical role of newborn screening.

Beauregard-Lacroix É et al.

Molecular Genetics and Metabolism Reports, 2025

Prospective Monitoring of Lyso-Gb1 on DBS Sample in Three Children Recognized at Newborn Screening for Gaucher Disease and Untreated.

Rossi C et al.

Children (basel, Switzerland), 2025

Natural history of inflammation and impaired autophagy in children with Gaucher disease identified by newborn screening.

Gragnaniello V et al.

Molecular Genetics and Metabolism Reports, 2025

Thyroid Function and Morphology in Gaucher Disease: Exploring the Endocrine Implications.

Kałużna M et al.

International Journal of Molecular Sciences, 2024

Twelve Years of the Gaucher Outcomes Survey (GOS): Insights, Achievements, and Lessons Learned from a Global Patient Registry.

Elstein D et al.

Journal of Clinical Medicine, 2024

Alpha-Synuclein mRNA Level Found Dependent on L444P Variant in Carriers and Gaucher Disease Patients on Enzyme Replacement Therapy.

Dubiela P et al.

Biomolecules, 2023

Long-term eliglustat treatment of Gaucher patients over up to 10 years in Vienna.

Stulnig TM

Wiener Klinische Wochenschrift, 2022

A case with Gaucher disease unable to reach enzyme replacement therapy because of COVID-19 quarantine: The first case from Turkey.

Yekedüz MK et al.

Turkish Archives of Pediatrics, 2021

A Cross-Sectional Retrospective Study of Non-Splenectomized and Never-Treated Patients with Type 1 Gaucher Disease.

Serratrice C et al.

Journal of Clinical Medicine, 2020

Early detection of lysosomal diseases by screening of cases of idiopathic splenomegaly and/or thrombocytopenia with a next-generation sequencing gene panel.

Muñoz G et al.

Jimd Reports, 2020

Molecular regulations and therapeutic targets of Gaucher disease.

Chen Y et al.

Cytokine & Growth Factor Reviews, 2018

Nine-year experience in Gaucher disease diagnosis at the Spanish reference center Fundación Jiménez Díaz.

Ortiz-Cabrera NV et al.

Molecular Genetics and Metabolism Reports, 2016

Lysosomal Storage Disorders in Egyptian Children.

Elmonem MA et al.

Indian Journal of Pediatrics, 2016

Novel mutations in the glucocerebrosidase gene of Indian patients with Gaucher disease.

Ankleshwaria C et al.

Journal of Human Genetics, 2014

Clinical utility of different bone marrow examination methods in the diagnosis of adults with sporadic Gaucher disease type 1.

Machaczka M et al.

Polskie Archiwum Medycyny Wewnetrznej, 2014

Substrate reduction therapy with miglustat for type 1 Gaucher disease: a retrospective analysis from a single institution.

Machaczka M et al.

Upsala Journal of Medical Sciences, 2012

Gaucher disease: when molecular testing and clinical presentation disagree -the novel c.1226A>G(p.N370S)--RecNcil allele.

Balwani M et al.

Journal of Inherited Metabolic Disease, 2011

Monitoring of Gaucher patients with a novel chitotriosidase assay.

Schoonhoven A et al.

Clinica Chimica Acta; International Journal of Clinical Chemistry, 2007

Select a paper to view details
UCSC Genome Browser·Imprint·Privacy·Terms·Feedback·Email Updates·

Regarding the variants extracted from papers and shown text snippets from research papers, the following holds: "Some rights reserved. This work permits non-commercial use, distribution and reproduction in any medium, provided the original author and source are credited."